NIH contract
Immy Wins $1.5M NIH Contract for Point-of-Care Talaromycosis Test
Talaromycosis is an infection caused by airborne inhalation of the fungus Talaromyces marneffei and is endemic in Southeast Asia.
RADx Issues $77.7M in New Contracts for SARS-CoV-2 Rapid Diagnostic Tests
The awards support the development, validation, scale-up, and manufacturing of the tests with the goal of bringing them to market as early as this year.
NIH Awards Qorvo Biotechnologies $24.4M for Rapid SARS-CoV-2 Antigen Test
The firm said that its point-of-care antigen testing platform uses high-frequency bulk acoustic wave sensors to detect SARS-CoV-2 at low limits of detection.
RAD-X Awards Six Phase 2 Contracts for COVID-19 Testing
The awards will support clinical validation, manufacturing, and scale up for SARS-CoV-2 viral antigen and molecular detection.
Fluidigm Finalizes $34M NIH Contract for SARS-CoV-2 Assay Production
Funding for Fluidigm's assay through NIH's RADx program was increased by approximately $22 million for a total contract value of up to about $34 million.